MPN Therapies in Practice: Drs. Verstovsek and Michaelis discuss emerging data for patients with ET, PV, and MF.
CLL: Drs. Wierda and O’Brien discuss recent progress and shifting standards of care.
CML: Drs. Cortes and Pemmaraju discuss developments and progress in 2021 and beyond.
What’s next for myeloma? Drs. Lonial and Usmani weigh the pros and cons of BCMA-targeted therapies.
How useful is MRD? Drs. Lonial and Usmani highlight the potential benefits and drawbacks in MM management.